Search results
Results from the WOW.Com Content Network
Lorcaserin, marketed under the brand name Belviq, [4] [5] was a weight-loss drug developed by Arena Pharmaceuticals. It reduces appetite by activating serotonin receptor the 5-HT 2C receptor in the hypothalamus , a region of the brain which is known to control appetite. [ 6 ]
Weight loss drugs have been developed since the early twentieth century, and many have been banned or withdrawn from the market due to adverse effects, including deaths; other drugs proved ineffective. Although many earlier drugs were stimulants such as amphetamines, in the early 2020s, GLP-1 receptor agonists became popular for weight loss.
Lorcaserin (Belviq) 2020 US Increased risk of cancer. [32] Lumiracoxib (Prexige) 2007–2008 Worldwide Liver damage Lysergic acid diethylamide (LSD) 1950s–1960s Marketed as a psychiatric drug; withdrawn after it became widely used recreationally. Now illegal in most of the world. Mebanazine: 1975 UK Hepatotoxicity, drug intereaction. [3 ...
After a long wait, patients now have a choice between two new obesity drugs. They couldn't be more different. Arena Pharmaceuticals' Belviq, the newest offering, looks relatively safe. The top ...
The drugs may not overlap much either; with its more severe side effect profile, Qsymia is likely to be prescribed to morbidly obese patients while Belviq finds a niche in patients that want a ...
For premium support please call: 800-290-4726 more ways to reach us
Top Prescription Weight Loss Pills. Anti-obesity medications (AOMs) date back to the 1940s — well before modern regulations from the FDA (U.S. Food and Drug Administration) (FDA) were in place.
For premium support please call: 800-290-4726 more ways to reach us